
Established in 1929, Hospital Clinica Biblica has grown from a modest clinic into one of Costa Rica’s leading medical institutions. With over 90 years of excellence, the hospital is recognized for its commitment to world-class healthcare, advanced medical technology, and compassionate patient care. As a Joint Commission International (JCI)-accredited hospital, Clinica Biblica upholds the highest standards in patient safety and medical excellence, attracting patients from around the world.
Advanced Technology & Facilities
Key Services

Founded in 2000, Hospital CIMA San José is a leading private healthcare institution known for its excellence in patient care, advanced medical technology, and highly specialized doctors. The hospital provides a wide range of medical services, including cardiology, oncology, neurology, orthopedics, urology, and reconstructive surgery. With a strong focus on innovation, research, and patient-centered care, CIMA San José is committed to delivering world-class healthcare solutions.
Advanced Technology & Facilities
Key Services at Hospital CIMA San José
Hospital CIMA San José is a benchmark for excellence in private healthcare, combining medical advancements, top specialists, and a commitment to compassionate, patient-centered care, making it a preferred choice for patients worldwide.

Hospital La Católica Costa Rica, established on March 16, 1963, is a leading private healthcare provider in Costa Rica. Founded by a group of Franciscan sisters and dedicated physicians, the hospital has upheld a strong commitment to patient well-being for decades. It has built a solid reputation for offering high-quality, personalized medical services, making it a trusted name in the country's healthcare sector.
Key Features of Hospital La Católica Costa Rica?
Through a patient-centered approach and commitment to continuous progress, Hospital La Católica Costa Rica remains a top choice for both local and international patients seeking quality healthcare in Costa Rica. With its dedication to excellence, expanding specialties, and modern medical solutions, the hospital continues to be a leading private healthcare provider in Costa Rica.



Oncology focuses on the diagnosis, treatment, and long-term management of cancer. According to the World Health Organization (WHO), cancer remains one of the leading causes of morbidity and mortality worldwide, increasing the global demand for structured, evidence-based oncology services. In recent years, Costa Rica has continued to modernize its oncology infrastructure, integrating molecular diagnostics, targeted therapies, immunotherapy protocols, advanced imaging technologies, and multidisciplinary tumor board models into routine clinical practice. These developments occur within a nationally regulated healthcare framework that emphasizes patient safety, institutional accountability, and professional oversight.
Costa Rica’s healthcare system operates under the supervision of the Ministry of Health (Ministerio de Salud de Costa Rica), with public services administered by the Caja Costarricense de Seguro Social (CCSS). Both public and private hospitals must comply with national licensing standards, radiation safety regulations, pharmaceutical oversight policies, infection-control requirements, and professional credentialing laws. Medical oncologists complete accredited medical degrees followed by residency training in internal medicine and subspecialty fellowship training in oncology. Board certification and registration with the national medical college are mandatory. Many specialists pursue additional training in subspecialties such as surgical oncology, radiation oncology, hematologic oncology, or palliative medicine. Continuous professional development through Continuing Medical Education (CME), academic conferences, and institutional peer-review processes is required to maintain licensure and ensure adherence to evolving international oncology standards.
Modern oncology centers in Costa Rica are equipped with infusion therapy units, sterile chemotherapy preparation pharmacies, digital pathology laboratories, high-resolution MRI and CT imaging systems, PET-CT in selected facilities, and radiation oncology departments with computerized treatment planning systems. Tertiary-care hospitals provide intensive care units (ICUs), surgical oncology collaboration, and multidisciplinary tumor boards that review complex cases. Several institutions maintain academic affiliations with national universities, contributing to specialist education and research initiatives. Clinical governance frameworks emphasize chemotherapy safety protocols, medication verification systems, radiation protection standards, infection prevention programs, and structured informed consent processes aligned with international patient-safety principles similar to those promoted by Joint Commission International (JCI).
For international patients exploring oncology treatment in Costa Rica, the process typically begins with gathering comprehensive medical documentation. In practice, hospitals commonly request pathology reports, biopsy results, imaging studies, laboratory findings, prior treatment summaries, and medication lists before conducting a preliminary review. Communication with international patient departments often occurs through secure digital platforms or scheduled video consultations, where administrative teams clarify documentation requirements and scheduling logistics. Many travelers from North America and Europe can enter Costa Rica without complex visa procedures for short stays, though requirements vary by nationality. The duration of stay depends on the type of therapy-systemic treatment cycles may require multiple weeks, while surgical oncology procedures may require 7-14 days of postoperative recovery depending on professional evaluation. English-speaking medical staff are frequently available in private institutions, and professional interpretation services are often arranged when needed. After returning home, patients are typically advised to coordinate follow-up care with their local oncologist to maintain continuity of monitoring and laboratory assessment.
Families commonly ask about chemotherapy safety standards, radiation shielding protocols, infection prevention measures for immunocompromised patients, pharmacy compounding oversight, and how medical records are shared internationally. These administrative and safety-related concerns are routinely addressed during pre-treatment coordination and reflect the importance of structured governance in cancer care.
Oncology services in Costa Rica incorporate modern diagnostic and therapeutic approaches aligned with international evidence-based standards. Molecular profiling, immunohistochemistry, and genetic testing increasingly inform individualized treatment planning. Targeted therapies and immunotherapies are integrated into systemic cancer management when clinically appropriate. Advanced imaging modalities, including high-resolution CT, MRI, and PET-CT in select centers, support accurate staging and treatment monitoring.
Strict protocols govern chemotherapy preparation and administration. Oncology pharmacies operate under sterile compounding standards with double-verification systems and medication traceability documentation to reduce error risk. Radiation oncology departments follow structured dosimetry planning and radiation safety guidelines to protect patients and staff. Anesthesia teams support surgical oncology procedures and invasive diagnostics under comprehensive monitoring standards. Post-treatment monitoring includes laboratory tracking, infusion observation protocols, imaging follow-up, and structured discharge planning.
Continuous professional education is central to oncology practice. Oncologists participate in CME programs, international conferences, and institutional case-review boards to maintain alignment with evolving standards of care. Treatment plans are individualized based on diagnostic findings, staging evaluation, and multidisciplinary consultation. Informed consent is required before initiating systemic therapy, radiation treatment, or surgery, and final clinical decisions depend exclusively on professional evaluation. At a national level, Costa Rica’s oncology services operate within a regulated and accountable healthcare system emphasizing modernization and patient safety oversight.
Chemotherapy (Systemic Therapy)
Chemotherapy involves the administration of cytotoxic medications designed to target rapidly dividing cancer cells. Diagnostic planning typically relies on pathology reports, imaging studies, and laboratory evaluation. Medications are prepared in sterile pharmacy units and administered in dedicated infusion centers under nursing supervision. Safety protocols include dose verification, infusion monitoring, and supportive medication management. The objective is systemic disease control within a structured safety framework.
Immunotherapy
Immunotherapy uses medications that enhance or modulate the body’s immune response against cancer cells. Biomarker testing and molecular diagnostics may guide treatment planning. Administration occurs in infusion centers under medical supervision with monitoring for immune-related reactions. Institutional oversight ensures adherence to pharmaceutical safety standards and documentation practices.
Radiation Therapy
Radiation therapy utilizes high-energy beams to target cancerous tissue while minimizing exposure to surrounding structures. Treatment planning involves imaging-based simulation and computerized dose calculation. Radiation safety protocols and quality assurance measures govern equipment calibration and delivery accuracy. Post-treatment monitoring supports evaluation of local tissue response.
Surgical Oncology
Surgical oncology addresses tumor removal when clinically indicated. Preoperative evaluation includes imaging studies, laboratory tests, and multidisciplinary tumor board review. Procedures are performed in sterile operating environments with anesthesia monitoring and postoperative ICU support when required. The objective is removal of malignant tissue within a structured governance framework.
Targeted Therapy
Targeted therapies focus on specific molecular pathways involved in cancer growth. Genetic or protein-expression testing guides therapy selection. These treatments may be administered orally or intravenously. Monitoring protocols include laboratory testing and imaging follow-up to evaluate therapeutic response and safety.
Supportive and Palliative Oncology Care
Supportive oncology services address symptom management, nutritional support, and psychosocial needs during cancer treatment. Clinical oversight ensures appropriate medication management and documentation. The goal is to maintain patient stability and comfort within an evidence-based framework.
Hospital CIMA San José
Accreditations:
Joint Commission International (JCI)
Licensed and regulated by the Ministry of Health of Costa Rica
Specializations:
Provides comprehensive oncology services including medical oncology, surgical oncology collaboration, infusion therapy, advanced imaging, and multidisciplinary tumor boards within a tertiary-care environment.
Clínica Bíblica Hospital
Accreditations:
Joint Commission International (JCI)
Regulated by the Ministry of Health
Specializations:
Offers oncology diagnostics, chemotherapy infusion units, and coordinated care with surgical and radiation oncology departments under structured governance protocols.
Hospital México (CCSS)
Accreditations:
Public tertiary-care hospital under CCSS
Ministry of Health oversight
Specializations:
Major public referral center providing oncology and hematology services, academic training programs, and multidisciplinary cancer management.
Hospital San Juan de Dios (CCSS)
Accreditations:
Public hospital regulated by CCSS
Ministry of Health oversight
Specializations:
Offers oncology services within a university-affiliated environment, supporting complex case management and specialist training.
Hospital Calderón Guardia (CCSS)
Accreditations:
Public tertiary-care institution under CCSS
Regulated by the Ministry of Health
Specializations:
Provides systemic therapy services, oncology diagnostics, and collaborative surgical oncology programs supported by ICU capacity.
Hospital Metropolitano
Accreditations:
Licensed by the Ministry of Health
Private regulated institution
Specializations:
Provides oncology consultations, infusion therapy, and imaging services within a structured private hospital setting.
| Procedure | Estimated Cost Range (USD) |
| Chemotherapy Cycle | $2,000-$6,000 |
| Immunotherapy Session | $3,000-$8,000 |
| Radiation Therapy (Per Course) | $6,000-$15,000 |
| Surgical Oncology Procedure | $10,000-$25,000 |
| PET-CT Scan | $1,500-$3,000 |
| Oncology Consultation | $150-$400 |
Note: The prices listed above are approximate, non-binding estimates provided for general informational purposes only. Actual treatment costs may vary based on individual clinical requirements, diagnostic findings, treatment complexity, materials or technology used, physician expertise, facility type, and duration of care. Final pricing is determined only after a professional evaluation by a licensed specialist or accredited medical institution.
Costa Rica’s oncology services operate within a nationally regulated healthcare system overseen by the Ministry of Health. Hospital licensing, pharmaceutical regulation, radiation safety standards, and professional certification requirements contribute to institutional accountability. Both public and private oncology centers follow documented chemotherapy preparation protocols, multidisciplinary case review processes, and infection control standards.
Specialist training pathways include formal residency and fellowship programs with mandatory professional registration. Continuous medical education and participation in international oncology networks support evidence-based practice. Hospitals commonly maintain electronic medical records and structured discharge documentation to facilitate transparency and continuity of care.
Costa Rica has implemented medical tourism oversight frameworks emphasizing ethical practice and patient protection. International patient departments frequently assist with document review, appointment coordination, and communication with referring physicians.
Restrictions and Practical Considerations
Eligibility for oncology treatment depends on clinical staging, prior treatment history, and professional evaluation. Some therapies require extended stays or multiple treatment cycles. Travel planning should account for immune status, recovery time, and follow-up coordination with a home-country oncologist. These logistical considerations are typically discussed during administrative planning.
Choosing cancer treatment abroad can feel uncertain and emotionally complex. National oversight, licensed specialists, structured pharmacy controls, and institutional governance frameworks are designed to provide reassurance that care is delivered within a regulated and accountable healthcare system.
Best Clinic Abroad is a medical travel facilitator that supports individuals exploring oncology treatment options internationally. It is not a medical provider, does not offer diagnosis, and does not influence clinical decisions. Its role is limited to non-clinical coordination and administrative guidance.
➤ Hospital coordination - Support communication and coordination with accredited hospitals
➤ Appointment support - Assist with scheduling and organizing consultations
➤ Communication assistance - Help patients understand next steps without replacing medical advice
➤ Logistical guidance - Offer non-clinical support related to travel planning
All medical decisions are made exclusively by licensed physicians and accredited hospitals, and you may contact Best Clinic Abroad if you would like structured assistance organizing documentation and communication with oncology institutions in Costa Rica.
How good are doctors in Costa Rica?
Doctors in Costa Rica complete accredited medical education and must register with national professional authorities. Oncology specialists undergo additional residency and fellowship training and are required to participate in continuing education to maintain licensure. As in any country, quality depends on individual credentials, institutional support, and adherence to regulatory standards.
Is Costa Rica a 2nd or 3rd world country?
The terms “2nd world” and “3rd world” are outdated classifications. Costa Rica is considered a middle-income country with stable public institutions and a structured healthcare system regulated by the Ministry of Health. It maintains national health coverage through the CCSS and hosts internationally accredited private hospitals.
How much does a doctor cost in Costa Rica?
The cost of consulting a doctor in Costa Rica varies depending on specialty, facility type, and complexity of care. In private settings, consultation fees are typically provided in advance, while costs within the public system may differ based on eligibility. An individualized estimate is generally provided after administrative review and clinical assessment.
Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. It reflects non-clinical observation of healthcare coordination processes and institutional practices in Costa Rica and does not represent direct medical practice. Diagnosis and treatment decisions should always be made in consultation with a licensed medical specialist based on individual clinical evaluation.
Last updated: February 2026